OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Trustees of Indiana University

3 Projects | 3 Researchers | $1,575,782 Invested

2026

Trustees of Indiana University

Jeffrey Dage, PhD

Novel Measures of Neuroinflammation in Alzheimer's disease

  • Funding Amount: $473,585
  • Organization Type:
  • Program: Diagnostics Accelerator
  • Target: Inflammation
  • Status: Active

2024

Trustees of Indiana University

Timothy Richardson, Phd

Lead Optimization of SHIP1 Inhibitors and Biomarker Development for the Treatment of Alzheimer's Disease

  • Funding Amount: $599,920
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Inflammation
  • Status: Active

Trustees of Indiana University

Andrew Saykin, PsyD, ABCN

Diagnostics Accelerator Speech & Language Consortium: Harmonized Repository for the Exploration of Speech and Language Biomarkers for Neurodegenerative Disease

  • Funding Amount: $502,277
  • Organization Type:
  • Program: Diagnostics Accelerator
  • Status: Active